NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
07 September 2024
| Name: | ADVANCE NANOTEK LIMITED (ANO) (This company subsequently changed its name to ADVANCE ZINCTEK LIMITED. You should refer to that name for Status.) | ||||||||||||
| ISIN: | AU000000ANO7 | ||||||||||||
| Date of Listing: | 24 February 2005 | ||||||||||||
| Subsequent Names: |
| ||||||||||||
| Former Names: |
|
Stock Exchange Status: (updated daily)
This company subsequently changed its name to ADVANCE ZINCTEK LIMITED. You should refer to that name for Stock Exchange Status.Legal Status: (updated monthly)
ACN: 079 845 855ABN: 54 079 845 855
Registration Date: 25 August 1997
Capital Gains Tax (CGT) Status: (updated at least quarterly)
This company subsequently changed its name and is now ADVANCE ZINCTEK LIMITED. You should refer to that name for Capital Gains Tax Status.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| FROM | TO | |
| ADVANCE ZINCTEK LIMITED | 23/11/2021 | |
| ADVANCE NANOTEK LIMITED | 25/10/2017 | 23/11/2021 |
| ADVANCED NANO TECHNOLOGIES LIMITED | 13/07/2016 | 25/10/2017 |
| ANTARIA LIMITED | 23/07/2008 | 13/07/2016 |
| ADVANCED NANOTECHNOLOGY LIMITED | 23/07/2008 |
Computershare Communication Services
117 Victoria St, West End QLD 4101
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 7 3237 2152
RegistryWebsite RegistryEmail
Expand this box to read and print
name changed to Advance Zinctek Limited | 23/11/2021 |
The suspension of trading in the securities of Advance NanoTek Limited will be lifted immediately, following the release by ANO of a response to the ASX Query letter in regards to the Patent Update. | 20/05/2020 |
The company issues a response to ASX Query Letter. | 20/05/2020 |
ANO has received the report from MSL Solution Providers in London on Saturday and the results are in line with the Board's expectations confirming the underlying science in the patent application (#2020900820) jointly owned with Astivita Limited. The two Boards are looking to commercialise the first product using zinc and hinokitiol, the subject of the patent application, which the Companies intend to market in Europe through Amazon UK. The Board is unable to predict the impact to revenue from royalties and the success of Astivita's product at this very early stage until Astivita release the product, and do not expect this to have a material effect on the results in FY2020. | 20/05/2020 |
The securities of Advance NanoTek Limited will be suspended from quotation immediately under Listing Rule 17.3, pending further inquiries by ASX. The securities will remain suspended until further notice. | 18/05/2020 |
ANO's securities will be reinstated to official quotation at the commencement of trading on 3 April 2020 following the release: on 2 April 2020 of ANO's announcement entitled "Retraction of Announcements" on the ASX market announcements platform and of this announcement on MAP, attaching ANO's response to further queries from ASX. | 02/04/2020 |
The ANO Board requests that if they can't agree, they retract all announcements since 16 March 2020, except for the patent application, ANO Business Update 26 March 2020 and the Appendix 3Y, from the ASX platform and have the suspension lifted. | 02/04/2020 |
ANO submitted its 11 page reply to the ASX Query Letter at 9:32am Brisbane time Tuesday morning, 31 March 2020. The Board still believes the announcement of 18 March 2020, not released to market, answered all the relevant questions appropriately. | 01/04/2020 |
On 19 March 2020, 20 March 2020 and 23 March 2020, ASX advised ANO and its advisers that its response to ASX's query letter were incomplete and unsatisfactory and that ANO's shares would remain in suspension until they provide proper responses to ASX's queries. ANO has not provided an updated response. ASX has today issued ANO with a further query letter outlining the further information ANO is required to provide and advising that they will remain in suspension until satisfactory responses have been received and ASX otherwise considers it appropriate to reinstate ANO to quotation. | 27/03/2020 |
ANO continues to produce zinc oxide and one of our large customers in the US has reconfirmed their prior orders for 80 MT plus for April, May and June. They are sending additional final products (powder and dispersions) to the US and Europe and will continue to do this on a weekly basis. The company has today received two new orders from Merck which doubles their orders for calendar 2020 to $3.2 million. They have placed significant orders for raw materials and are investing in spare parts to ensure they have continuous supply of Alusion to Merck over the next 12 months. ANO is looking into the production of zinc gluconate with lab trials about to start. Software has been installed successfully by SenterpriSys Limited to allow key functions within the business to be completed by staff from home if required. ASX have raised rumours in regards to margin calls by Directors on Wednesday morning, 18 March 2020. The Board confirms to all shareholders that there are no margin loans in place by any Director. The Board is going to investigate listing on NASDAQ. | 26/03/2020 |
The company has just received a query letter from the enforcement team at 2:28pm. The ASX release was submitted to the ASX on 18 March 2020 and requested the voluntary suspension be lifted. Since then, ASX imposed a temporary suspension until the query letter is answered. | 19/03/2020 |
The securities of Advance NanoTek Limited will remain suspended from quotation under Listing Rule 17.3, pending further enquires by ASX. | 19/03/2020 |
ANO confirms that it has prepared an ASX announcement for release to market today. However, they will be receiving a query letter from the Enforcement Team which they are yet to receive hence delaying this release to market. | 18/03/2020 |
The securities of Advance NanoTek Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of ANO, pending the release of an announcement regarding the patent application. | 18/03/2020 |
name changed from Advanced Nano Technologies Limited | 25/10/2017 |
name changed to Advance Zinctek Limited | 23/11/2021 |
The suspension of trading in the securities of Advance NanoTek Limited will be lifted immediately, following the release by ANO of a response to the ASX Query letter in regards to the Patent Update. | 20/05/2020 |
The company issues a response to ASX Query Letter. | 20/05/2020 |
ANO has received the report from MSL Solution Providers in London on Saturday and the results are in line with the Board's expectations confirming the underlying science in the patent application (#2020900820) jointly owned with Astivita Limited. The two Boards are looking to commercialise the first product using zinc and hinokitiol, the subject of the patent application, which the Companies intend to market in Europe through Amazon UK. The Board is unable to predict the impact to revenue from royalties and the success of Astivita's product at this very early stage until Astivita release the product, and do not expect this to have a material effect on the results in FY2020. | 20/05/2020 |
The securities of Advance NanoTek Limited will be suspended from quotation immediately under Listing Rule 17.3, pending further inquiries by ASX. The securities will remain suspended until further notice. | 18/05/2020 |
ANO's securities will be reinstated to official quotation at the commencement of trading on 3 April 2020 following the release: on 2 April 2020 of ANO's announcement entitled "Retraction of Announcements" on the ASX market announcements platform and of this announcement on MAP, attaching ANO's response to further queries from ASX. | 02/04/2020 |
The ANO Board requests that if they can't agree, they retract all announcements since 16 March 2020, except for the patent application, ANO Business Update 26 March 2020 and the Appendix 3Y, from the ASX platform and have the suspension lifted. | 02/04/2020 |
ANO submitted its 11 page reply to the ASX Query Letter at 9:32am Brisbane time Tuesday morning, 31 March 2020. The Board still believes the announcement of 18 March 2020, not released to market, answered all the relevant questions appropriately. | 01/04/2020 |
On 19 March 2020, 20 March 2020 and 23 March 2020, ASX advised ANO and its advisers that its response to ASX's query letter were incomplete and unsatisfactory and that ANO's shares would remain in suspension until they provide proper responses to ASX's queries. ANO has not provided an updated response. ASX has today issued ANO with a further query letter outlining the further information ANO is required to provide and advising that they will remain in suspension until satisfactory responses have been received and ASX otherwise considers it appropriate to reinstate ANO to quotation. | 27/03/2020 |
ANO continues to produce zinc oxide and one of our large customers in the US has reconfirmed their prior orders for 80 MT plus for April, May and June. They are sending additional final products (powder and dispersions) to the US and Europe and will continue to do this on a weekly basis. The company has today received two new orders from Merck which doubles their orders for calendar 2020 to $3.2 million. They have placed significant orders for raw materials and are investing in spare parts to ensure they have continuous supply of Alusion to Merck over the next 12 months. ANO is looking into the production of zinc gluconate with lab trials about to start. Software has been installed successfully by SenterpriSys Limited to allow key functions within the business to be completed by staff from home if required. ASX have raised rumours in regards to margin calls by Directors on Wednesday morning, 18 March 2020. The Board confirms to all shareholders that there are no margin loans in place by any Director. The Board is going to investigate listing on NASDAQ. | 26/03/2020 |
The company has just received a query letter from the enforcement team at 2:28pm. The ASX release was submitted to the ASX on 18 March 2020 and requested the voluntary suspension be lifted. Since then, ASX imposed a temporary suspension until the query letter is answered. | 19/03/2020 |
The securities of Advance NanoTek Limited will remain suspended from quotation under Listing Rule 17.3, pending further enquires by ASX. | 19/03/2020 |
ANO confirms that it has prepared an ASX announcement for release to market today. However, they will be receiving a query letter from the Enforcement Team which they are yet to receive hence delaying this release to market. | 18/03/2020 |
The securities of Advance NanoTek Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of ANO, pending the release of an announcement regarding the patent application. | 18/03/2020 |
name changed from Advanced Nano Technologies Limited | 25/10/2017 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 17/11/2021 | Lev Mizikovsky | 32,609 | $3.400 | $110,871 |
| 10/11/2021 | Lev Mizikovsky | 39,004 | $3.400 | $132,614 |
| 08/11/2021 | Lev Mizikovsky | 124,842 | $3.540 | $441,963 |
| 03/11/2021 | Lev Mizikovsky | 6,154 | $3.400 | $20,924 |
| 05/10/2021 | Lev Mizikovsky | 20,000 | $3.560 | $71,200 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Lev Mizikovsky | Non Exec Chairman | 10/04/2015 |
| Geoff Acton | Managing Director, Company Secretary | 15/07/2015 |
| Laurie Lefcourt | Independent Director | 28/06/2019 |
| Rade Dudurovic | Non Exec Director | 02/11/2011 |
| Narelle Lynch | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Ron Higham | Non Exec Director | 06/05/2013 | 16/03/2016 |
| Paul Pisasale | Non Exec Director | 25/02/2013 | 30/06/2015 |
| John Young | Non Exec Director | 05/10/2007 | 06/05/2013 |
| Deborah Cooper | Non Exec Director | 20/09/2010 | 29/08/2012 |
| Robert Mangioni | Non Exec Chairman | 04/11/2004 | 06/02/2012 |
| Deana Cesari | CFO | 24/02/2005 | 06/02/2012 |
| Bruce Cameron | Executive Chairman | 18/12/2006 | 22/11/2010 |
| Paul McCormick | CEO | 10/01/2000 | 02/02/2010 |
| David Griffiths | Non Exec Director | 11/12/2003 | 20/11/2008 |
| Harold Clough | Chairman | 10/01/2000 | 21/11/2007 |
| Thibaut Mortier | Executive Director | 05/10/2007 | 29/08/2000 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2024 Investogain Pty Limited. All rights reserved.
